| NeoRecormon 3000 IU Solution for injection EU/1/97/031/031 |
Epoetin beta |
Roche Registration GmbH |
— |
| NeoRecormon 3000 IU Solution for injection EU/1/97/031/032 |
Epoetin beta |
Roche Registration GmbH |
— |
| NeoRecormon 4000 IU Solution for injection EU/1/97/031/041 |
Epoetin beta |
Roche Registration GmbH |
— |
| NeoRecormon 4000 IU Solution for injection EU/1/97/031/042 |
Epoetin beta |
Roche Registration GmbH |
— |
| NeoRecormon 500 IU Solution for injection EU/1/97/031/025 |
Epoetin beta |
Roche Registration GmbH |
— |
| NeoRecormon 500 IU Solution for injection EU/1/97/031/026 |
Epoetin beta |
Roche Registration GmbH |
— |
| NeoRecormon 5000 IU Solution for injection EU/1/97/031/033 |
Epoetin beta |
Roche Registration GmbH |
— |
| NeoRecormon 5000 IU Solution for injection EU/1/97/031/034 |
Epoetin beta |
Roche Registration GmbH |
— |
| NeoRecormon 6000 IU Solution for injection EU/1/97/031/043 |
Epoetin beta |
Roche Registration GmbH |
— |
| NeoRecormon 6000 IU Solution for injection EU/1/97/031/044 |
Epoetin beta |
Roche Registration GmbH |
— |
| Ocrevus 300 mg concentrate for solution for infusion EU/1/17/1231/001-002 |
Ocrelizumab |
Roche Registration GmbH |
— |
| Ocrevus 920 mg solution for injection EU/1/17/1231/003 |
Ocrelizumab |
Roche Registration GmbH |
— |
| Perjeta 420 mg concentrate for solution for infusion EU/1/13/813/001 |
Pertuzumab |
Roche Registration GmbH |
— |
| Phesgo 1200 mg/600 mg solution for injection EU/1/20/1497/001 |
Pertuzumab, Trastuzumab |
Roche Registration GmbH |
— |
| Phesgo 600 mg/600 mg solution for injection EU/1/20/1497/002 |
Pertuzumab, Trastuzumab |
Roche Registration GmbH |
— |
| Piasky EU/1/24/1848/001 |
Crovalimab |
Roche Registration GmbH |
— |
| Polivy 140 mg powder for concentrate for solution for infusion EU/1/19/1388/001 |
Polatuzumab Vedotin |
Roche Registration GmbH |
— |
| Polivy 30 mg powder for concentrate for solution for infusion EU/1/19/1388/002 |
Polatuzumab Vedotin |
Roche Registration GmbH |
— |
| RoActemra 162 mg Solution for injection EU/1/08/492/007-008 |
Tocilizumab |
Roche Registration GmbH |
— |
| RoActemra 162 mg Solution for injection EU/1/08/492/009-010 |
Tocilizumab |
Roche Registration GmbH |
— |
| RoActemra 20 mg/ml Concentrate for solution for infusion EU/1/08/492/001-006 |
Tocilizumab |
Roche Registration GmbH |
— |
| Rozlytrek 100 mg hard capsules EU/1/20/1460/001 |
Entrectinib |
Roche Registration GmbH |
— |
| Rozlytrek 200 mg hard capsules EU/1/20/1460/002 |
Entrectinib |
Roche Registration GmbH |
— |
| Rozlytrek 50 mg film-coated granules in sachet EU/1/20/1460/003 |
Entrectinib |
Roche Registration GmbH |
— |
| Tamiflu 30 mg hard capsules EU/1/02/222/003 |
Oseltamivir |
Roche Registration GmbH |
— |
| Tamiflu 45 mg hard capsules EU/1/02/222/004 |
Oseltamivir |
Roche Registration GmbH |
— |
| Tamiflu 6 mg/ml powder for oral suspension EU/1/02/222/005 |
Oseltamivir phosphate |
Roche Registration GmbH |
— |
| Tamiflu 75 mg hard capsules EU/1/02/222/001 |
Oseltamivir phosphate |
Roche Registration GmbH |
— |
| Tecentriq 1200 mg concentrate for solution for infusion EU/1/17/1220/001 |
Atezolizumab |
Roche Registration GmbH |
— |
| Tecentriq 1875 mg solution for injection EU/1/17/1220/003 |
Atezolizumab |
Roche Registration GmbH |
— |
| Tecentriq 840 mg concentrate for solution for infusion EU/1/17/1220/002 |
Atezolizumab |
Roche Registration GmbH |
— |
| Vabysmo 120 mg/mL solution for injection EU/1/22/1683/001 |
Faricimab |
Roche Registration GmbH |
— |
| Xofluza 2 mg/mL granules for oral suspension EU/1/20/1500/005 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xofluza 20 mg film-coated tablets EU/1/20/1500/001 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xofluza 40 mg film-coated tablets EU/1/20/1500/002 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xofluza 80 mg film-coated tablets EU/1/20/1500/003 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Zelboraf 240 mg film-coated tablets EU/1/12/751/001 |
Vemurafenib |
Roche Registration GmbH |
— |